The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
prompted scientific, medical, and biotech communities to investigate infection-and vaccine …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of
concern comprises several sublineages, with BA. 2 and BA. 2.12. 1 having replaced the …

Differences in SARS-CoV-2-specific immune responses have been observed between
individuals following natural infection or vaccination. In addition to already known factors …

The COVID-19 response strategies in Chinese mainland were recently adjusted due to the
reduced pathogenicity and enhanced infectivity of Omicron subvariants. In Chengdu, China …

We report SARS-CoV-2 neutralizing antibody titers in sera of triple-vaccinated individuals
who received a booster dose of an original monovalent or a bivalent BA. 1-or BA. 4/BA. 5 …

Background and Methods The SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2) Omicron (B. 1.1. 529) variant is the antigenically most distinct variant to date …

ABSTRACT The SARS-CoV-2 Omicron variant is characterized by substantial changes in
the antigenic structure of the Spike (S) protein. Therefore, antibodies induced by primary …

Viruses are submicroscopic, obligate intracellular parasites that carry either DNA or RNA as
their genome, protected by a capsid. Viruses are genetic entities that propagate by using the …

Vaccines are known to function as the most effective interventional therapeutics for
controlling infectious diseases, including polio, smallpox, rabies, tuberculosis, influenza and …

Omicron variants of SARS-CoV-2 are globally dominant and infection rates are very high in
children. We measure immune responses following Omicron BA. 1/2 infection in children …